EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Oral Oncology Reports

ISSN 2772-9060 · Elsevier BV

Latest articles

  1. Neoadjuvant cytokine (IRX-2) immunotherapy for resectable oral cavity carcinoma: Final results of the INSPIRE trial

    Gregory T. Wolf, Emily Bellile, Celine Mauquoi, Ariane Nguyen, Maureen Sartor, Siyu Liu, Laura Rozek, Jonathan B. McHugh, Jeff Moyer, Mihir Patel, Nabil Saba, Audrey Erman, Wanessa A. Martins, Jason G. Newman, Michael Kaplan, Frabicio Oliveira, Ana Paula Victorina, R. Bryan Bell, Gustavo C. Girotto, Jorge Nieva, Joseph Valentino, Greg Krempl, Claudio R. Cernea, Dennis Kraus, Kevin Higgins, Felipe JSM. Cruz, Aru Panwar, Clodoaldo Z. Campos, Jim McCaul

    Published: 2025-03DOI: 10.1016/j.oor.2024.100706

Volumes

2026 · 302025 · 792024 · 5632023 · 1132022 · 6

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.